Umberto De Marca
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Umberto De Marca has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Beatrice D’aRco
Neurology Unit, University Hospital “San Giovanni di Dio e Ruggi d’Aragona”, Salerno, Italy
1 shared publication- Caterina Giordano
Univ Salerno, Surg & Dent Scuola Med Salernitana, Dept Med, Neurosci Sect, Via Allende 43, I-84081 Baronissi, SA, Italy
1 shared publication - Federico Di Filippo
Neurology Unit, University Hospital “San Giovanni di Dio e Ruggi d’Aragona”, Salerno, Italy
1 shared publication - Francesca Barra
Neurology Unit, University Hospital “San Giovanni di Dio e Ruggi d’Aragona”, Salerno, Italy
1 shared publication - Maria Di Gregorio
Department of Neurology and Stroke, Ospedali Riuniti San Giovanni di Dio e Ruggi d’Aragona, Salerno, Italy
1 shared publication - Miriam Caterino
Neurology Unit, University Hospital “San Giovanni di Dio e Ruggi d’Aragona”, Salerno, Italy
1 shared publication
Latest Publications
- 27 December 2023
- Published by Springer Nature in Neurological Sciences
- Vol. 45 (6) , 2807-2810
Bariatric surgery and dimethyl fumarate-induced lymphopenia in patients with multiple sclerosis
Introduction Lymphopenia is a known side effect of dimethyl fumarate (DMF), a disease-modifying therapy (DMT) for patients with multiple sclerosis (pwMS). A body mass index ≥ 30 kg/m2 has been identified as a protective factor; however, no data are available on lymphopenia in pwMS undergoing to weight loss due to bariatric surgery. Methods We described two pwMS with history of bariatric surgery who started DMF as DMT. Results The two pwMS experienced persistent lymphopenia during DMF-treatment, which was resolved after its discontinuation. Conclusions Several mechanisms might modify DMF pharmacokinetic profiles after bariatric surgery and its bioavailability. Absolute lymphocyte count should be monitored in pwMS treated with DMF and history of bariatric surgery and weight loss.
- 27 December 2023
- Published by Springer Nature in Neurological Sciences
- Vol. 45 (6) , 2807-2810
Bariatric surgery and dimethyl fumarate-induced lymphopenia in patients with multiple sclerosis
Introduction Lymphopenia is a known side effect of dimethyl fumarate (DMF), a disease-modifying therapy (DMT) for patients with multiple sclerosis (pwMS). A body mass index ≥ 30 kg/m2 has been identified as a protective factor; however, no data are available on lymphopenia in pwMS undergoing to weight loss due to bariatric surgery. Methods We described two pwMS with history of bariatric surgery who started DMF as DMT. Results The two pwMS experienced persistent lymphopenia during DMF-treatment, which was resolved after its discontinuation. Conclusions Several mechanisms might modify DMF pharmacokinetic profiles after bariatric surgery and its bioavailability. Absolute lymphocyte count should be monitored in pwMS treated with DMF and history of bariatric surgery and weight loss.